Estimation of the value-based price of a blood test for Alzheimer’s disease pathology in primary and specialty care in the U.S.
The results project substantial cost savings from implementing a blood test for AD pathology within the diagnostic pathway based on modeling results, which future research should confirm with actual data.
Authors
- Jorge G. Ruiz (ORCID: https://orcid.org/0000-0003-3069-8502)
- Soeren Mattke (ORCID: https://orcid.org/0000-0003-4666-9132)
- David A. Merrill (ORCID: https://orcid.org/0000-0003-2181-3839)
- Mark Hanson (ORCID: https://orcid.org/0000-0002-8403-6275)
- Kim G. Johnson (ORCID: https://orcid.org/0000-0002-8793-2489)
- Jiahe Chen (ORCID: https://orcid.org/0000-0002-4119-4265)
- Catherine Leahy
- Victoria Shada
Institutions
- LAC+USC Medical Center (US)
- Duke University (US)
- Memorial Healthcare System (US)
- Pacific Heart Institute (US)
- Wake Forest University (US)
Publication Details
- Journal
- The Journal of Prevention of Alzheimer s Disease
- Published
- 2025-06-09
- DOI
- https://doi.org/10.1016/j.tjpad.2025.100219
- Citations
- 5
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 15.66